RELAPSE
Clinical trials for RELAPSE explained in plain language.
Never miss a new study
Get alerted when new RELAPSE trials appear
Sign up with your email to follow new studies for RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New program helps men in pakistan stay clean after rehab
Disease control CompletedThis study tested a culturally adapted relapse prevention program (RPM-08) for men with substance use disorder in Pakistan. 70 male participants in residential rehab either received the program plus usual care or usual care alone. The program involved eight weekly group sessions …
Matched conditions: RELAPSE
Phase: NA • Sponsor: Universiti Sains Malaysia • Aim: Disease control
Last updated May 26, 2026 03:55 UTC
-
New pill shows promise in early trial for tough blood cancers
Disease control CompletedThis early-phase study tested an experimental pill called LP-108, taken alone or with another drug (azacitidine), in 32 adults with blood cancers (MDS, CMML, or AML) that returned or didn't respond to prior therapy. The main goals were to find the safest dose and understand how t…
Matched conditions: RELAPSE
Phase: PHASE1 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Immune cell therapy shows promise for tough lymphoma
Disease control CompletedThis study tested a treatment using specially engineered immune cells (CD19 CAR T cells) in 20 adults with a type of blood cancer called B-cell lymphoma that had come back or not responded to standard therapy. The cells were given in three doses over three days. The goal was to s…
Matched conditions: RELAPSE
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 20, 2026 11:54 UTC